IPAD-DB ID | D01297 |
Name | alpha-Chlorohydrin |
Category | Drugs |
2D Structure |
|
3D Structure | |
Molecular Formula | C 3 H 7 C l O 2 |
Molecular Weight | 110.54 |
IUPAC Name | 3-chloropropane-1,2-diol |
InChI | InChI=1S/C3H7ClO2/c4-1-3(6)2-5/h3,5-6H,1-2H2 |
InChIKey | SSZWWUDQMAHNAQ-UHFFFAOYSA-N |
Canonical SMILES | C(C(CCl)O)O |
PubChem CID | 7290 |
DrugBank Accession Number | - |
CAS Registry Number | - |
Ki | - |
EC50 | - |
IC50 | - |
Inhibition | - |
Toxicity | - |
ROS(reactive oxygen species) | - |
Metal Chelating | - |
BBB(blood-brain barrier) | - |
Target Protein | Aβ |
Effects | - |
Research Models | - |
Ref. Link |
Molecular Weight(Computed by SwissADME) | 110.54 |
Hac(Computed by SwissADME) | 6 |
Volume(Computed by ADMETlab 2.0) | 93.236 |
Density(Computed by ADMETlab 2.0) | 1.18 |
nRing(Computed by ADMETlab 2.0) | 0 |
MaxRing(Computed by ADMETlab 2.0) | 0 |
nHet(Computed by ADMETlab 2.0) | 3 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 0 |
Flexibility(Computed by ADMETlab 2.0) | inf |
Stero Centers(Computed by ADMETlab 2.0) | 1 |
LogS(Computed by ADMETlab 2.0) | 0.735 |
LogD(Computed by ADMETlab 2.0) | -1.068 |
logP(Computed by ADMETlab 2.0) | -0.512 |
TPSA(Computed by SwissADME) | 40.46 |
Hbond Acceptor(Computed by SwissADME) | 2 |
Hbond Donor(Computed by SwissADME) | 2 |
Rotatable Bonds(Computed by SwissADME) | 2 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | No |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -7.32 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 4 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 2 |
Bioavailability Score(Computed by SwissADME) | 0.55 |